Erratum: Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth (J Clin Invest. (2021) 131: 10 (e146777) DOI: 10.1172/JCI146777)

Michael D. Nyquist, Lisa S. Ang, Alexandra Corella, Ilsa M. Coleman, Michael P. Meers, Anthony J. Christiani, Cordell Pierce, Derek H. Janssens, Hannah E. Meade, Arnab Bose, Lauren Brady, Timothy Howard, Navonil de Sarkar, Sander B. Frank, Ruth F. Dumpit, James T. Dalton, Eva Corey, Stephen R. Plymate, Michael C. Haffner, Elahe A. MostaghelPeter S. Nelson

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Erratum: Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth (J Clin Invest. (2021) 131: 10 (e146777) DOI: 10.1172/JCI146777)'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology